Section Arrow
AXSM.NASDAQ
- Axsome Therapeutics
Quotes are at least 15-min delayed:2024/12/25 00:58 EST
Last
 87.01
+0.06 (+0.07%)
Day High 
87.38 
Prev. Close
86.95 
1-M High
102.42 
Volume 
254.90K 
Bid
87.02
Ask
87.5
Day Low
85.29 
Open
86.34 
1-M Low
85.1045 
Market Cap 
4.21B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 92.23 
20-SMA 95.6 
50-SMA 93.39 
52-W High 105 
52-W Low 64.11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.58/-1.41
Enterprise Value
4.40B
Balance Sheet
Book Value Per Share
1.92
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
270.60M
Operating Revenue Per Share
4.61
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.3853-0.0178-4.42%-- 
CMNDClearmind Medicine1.72+0.5+40.98%0.16PE
CEROCERo Therapeutics Holdings0.0623+0.0118+23.37%-- 
ATNF180 Life Sciences Corp2.9+1.03+55.08%0.23PE
RXRXRecursion Pharmaceuticals7.24+0.25+3.58%-- 
Quotes are at least 15-min delayed:2024/12/25 00:58 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.